Download the free e-book on peptides, hormones and pharmaceuticals for longevity, health and performance here: get the e-book
Most discussions of peptide therapy treat compounds as individual tools to be selected and used one at a time. The combination stacks available in the catalogue represent a different approach, one grounded in the observation that certain compounds address different steps in the same biological process, and that addressing multiple steps simultaneously produces an effect greater than what any single compound achieves alone.
Understanding the logic behind the combination stacks — why specific compounds are paired, what each contributes that the other does not, and when a combination is genuinely superior to its individual components — is foundational to building protocols intelligently rather than simply accumulating compounds.
The principle behind combination stacking
The biological processes most relevant to optimization — tissue repair, growth hormone secretion, cognitive function, sexual health — are not single-step events. They are multi-step cascades involving multiple cell types, multiple signaling molecules, and multiple regulatory checkpoints. A compound that addresses one step in the cascade produces a partial effect. A combination that addresses multiple steps simultaneously produces a more complete intervention.
The key distinction that separates a genuinely synergistic combination from simply taking more compounds is mechanistic complementarity. Two compounds that work through the same mechanism at the same step in a pathway add up to more of the same thing. Two compounds that work through different mechanisms at different steps in the same pathway produce something qualitatively different — an intervention that is more complete because it covers more of the biological process rather than simply amplifying one part of it.
This distinction shapes how the combination stacks in the catalogue were assembled and how they should be evaluated.
Wolverine: BPC-157 and TB-500
The Wolverine stack pairs BPC-157 and TB-500 in a single vial, and it is the most widely used combination in the recovery and repair category for good reason. The two compounds address tissue repair through mechanisms that are complementary at the most fundamental level.
BPC-157 works primarily at the local level. It promotes angiogenesis at the injury site through VEGF upregulation, stimulates fibroblast proliferation and collagen synthesis in the damaged tissue, and modulates the local inflammatory environment to support repair progression. Its mechanism is anchored to the injury site — it improves the biological conditions for repair where the damage has occurred.
TB-500, a synthetic fragment of Thymosin Beta-4, works primarily at the systemic level. It promotes the migration of repair-relevant cells throughout the body, making it easier for the cells that need to reach an injury site to do so. It supports angiogenesis through a different pathway than BPC-157, adding to rather than duplicating the vascular support. And it reduces the formation of excess scar tissue that can limit the function of healed tissue compared to the original.
The combination addresses tissue repair from both the local and systemic dimensions simultaneously. BPC-157 improves the local biological environment for repair. TB-500 ensures the repair cells can reach that environment efficiently and that the resulting tissue is structurally optimal. Neither compound fully addresses what the other provides, which is precisely what makes the combination more effective than either alone for comprehensive tissue repair.
Wolverine 2: BPC-157, KPV, and TB-500
Wolverine 2 adds KPV to the BPC-157 and TB-500 base, extending the stack with an anti-inflammatory dimension that addresses one of the most common obstacles to effective tissue repair.
KPV is a tripeptide derived from alpha-melanocyte stimulating hormone with potent anti-inflammatory properties that work at the cellular level within the tissue. It modulates NF-κB signaling, one of the primary pathways through which inflammatory gene expression is upregulated in damaged tissue, and it supports the resolution of inflammation in ways that favor repair progression rather than perpetuation of the inflammatory phase.
The addition of KPV to the Wolverine base stack addresses a specific clinical problem: the situations where ongoing or excessive inflammation is the primary obstacle to effective repair. Chronic tendinopathies, inflammatory bowel presentations, and systemic inflammatory conditions all involve inflammatory activity that impairs the tissue environment in ways that BPC-157 and TB-500 alone do not fully address. KPV adds the targeted anti-inflammatory resolution mechanism that completes the repair environment.
Klow: BPC-157, GHK-Cu, KPV, and TB-500
The Klow stack is the most comprehensive of the repair combinations, adding GHK-Cu to the Wolverine 2 base to include a tissue remodeling and collagen synthesis dimension that the other compounds do not directly address.
GHK-Cu, copper peptide, supports the remodeling phase of tissue repair — the process by which the initial scaffolding of new tissue is refined and strengthened into mature, functional tissue. It drives collagen synthesis and cross-linking, supports the production of elastin and other structural proteins, promotes angiogenesis through yet another pathway, and has gene expression effects that shift cells toward a more regenerative state.
In the context of tissue repair, GHK-Cu addresses the remodeling phase that BPC-157, KPV, and TB-500 move the tissue toward but do not directly drive. The result is a stack that covers the full repair sequence from the initial inflammatory phase through proliferation and angiogenesis to final tissue remodeling — each compound addressing a distinct phase of the process that the others do not primarily target.
GLOW: GHK-Cu, BPC-157, and TB-500
The GLOW stack from STK pharmacy combines GHK-Cu, BPC-157, and TB-500 in a ratio optimized for skin, connective tissue, and general recovery applications where the anti-inflammatory resolution of KPV is less critical and the GHK-Cu tissue remodeling dimension is the priority.
The distinction between GLOW and Wolverine 2 reflects a difference in primary application context. GLOW is oriented toward applications where tissue quality and remodeling are the primary goals — skin health, connective tissue maintenance, and recovery applications where the inflammatory burden is not the limiting factor. Wolverine 2 is oriented toward applications where active inflammation is a significant component and the KPV anti-inflammatory mechanism adds something clinically meaningful.
Both stacks use BPC-157 and TB-500 as their foundation. The choice between them depends on whether the primary need is tissue remodeling support, where GLOW's GHK-Cu emphasis fits best, or anti-inflammatory resolution alongside repair, where Wolverine 2's KPV addition is most relevant.
DSIP/BPC-157/CJC-1295: the sleep and recovery combination
This combination takes a different approach than the repair stacks, addressing the overnight window as an integrated recovery opportunity rather than a single biological process.
DSIP promotes slow-wave sleep architecture and regulates cortisol secretion in alignment with the natural circadian rhythm. By supporting deeper slow-wave sleep, it creates the biological conditions in which the other two compounds do their most significant work.
BPC-157 contributes its systemic repair properties during the overnight period when the body's repair processes are most active. The tissue repair, gut mucosal maintenance, and anti-inflammatory effects that BPC-157 produces are most aligned with the overnight repair window.
CJC-1295's long-acting GHRH analogue mechanism stimulates growth hormone release in alignment with the natural overnight GH pulse. The body's primary growth hormone secretion occurs during deep slow-wave sleep, and CJC-1295 ensures the pituitary receives sustained GHRH stimulation through the night.
The synergy in this combination is temporal as much as mechanistic. DSIP creates the sleep architecture that makes the overnight window maximally productive. CJC-1295 amplifies the growth hormone pulse that occurs during that deep sleep. BPC-157 supports the tissue repair that is most active during that window. Each compound's contribution is enhanced by what the others are doing simultaneously.
Pinealon/PE22-28/Selank: the cognitive combination
The cognitive combination addresses brain health from three distinct angles simultaneously, each targeting a different aspect of neurological function.
Pinealon is a peptide bioregulator with neuroprotective properties and effects on gene expression in brain tissue. Its mechanism involves direct interaction with DNA in neural cells, supporting the expression of genes involved in cellular repair and maintenance. It also supports pineal gland function and the circadian regulatory role that has downstream effects on cognitive and mood stability.
PE22-28 is a peptide fragment studied for its neuroprotective and neuroplasticity-supporting properties, with particular relevance to synaptic integrity and the cellular processes that maintain functional neural connections over time.
Selank works through GABA receptor modulation and BDNF support to reduce anxiety and stress response while supporting the neuroplasticity and stress resilience that determine how well the brain functions under demand.
The three compounds address cognitive health from neuroprotection through gene expression, synaptic maintenance, and stress response modulation — mechanisms that are distinct enough to be genuinely complementary and important enough individually to be worth addressing simultaneously in anyone for whom cognitive health and long-term neurological function are priorities.
Semax/Selank: the stress and cognitive performance combination
The Semax and Selank pairing is one of the most straightforward in the catalogue in terms of mechanistic logic. Semax drives BDNF production and supports the brain's stress response toward resilience. Selank modulates GABA activity and reduces anxiety-driven cognitive interference without sedation.
The two compounds address the same general outcome — better cognitive function under stress and demand — through mechanisms that are complementary. Semax builds the neuroplastic capacity that makes the brain more capable. Selank reduces the anxiety and stress reactivity that prevents that capacity from being fully expressed. Together they address both the ceiling of cognitive performance and the floor of stress-driven impairment.
The Tadalafil/Oxytocin/PT-141 combination
The Thrill Pill combination addresses sexual health from the three primary dimensions that together determine a comprehensive sexual experience: vascular response, emotional bonding and connection, and central desire initiation.
Tadalafil provides the vascular support through PDE5 inhibition, ensuring adequate blood flow for physiological arousal response. Oxytocin supports the bonding and connection dimension through its role in social attachment and the emotional context of sexual experience. PT-141 drives the central nervous system initiation of desire through melanocortin receptor activation in the hypothalamus.
These three mechanisms are genuinely distinct — tadalafil works on blood vessels, oxytocin works on bonding and social connection neurobiology, and PT-141 works on the central nervous system initiation of desire. Together they address sexual health more comprehensively than any single mechanism can.
When a combination is worth the added complexity
The combination stacks are most appropriate when the biological process being addressed genuinely involves multiple distinct mechanisms that are each limiting factors in the outcome, and when the individual compounds in the stack are all contributing something that the others do not provide.
The combinations in the catalogue meet this standard. Each was assembled around mechanistic complementarity rather than simply more compounds producing more effect. The practical result is that for the applications these stacks address — comprehensive tissue repair, overnight recovery, cognitive performance, and sexual health — the combination produces something qualitatively different from any of its individual components.
For people building protocols from individual compounds, the combination stacks offer a practical simplification that reduces the number of separate vials while ensuring that the multiple mechanisms needed for comprehensive effect are all addressed. For people for whom one component of a combination is more relevant than the others, the individual compounds remain available to build a more customized approach.
This content is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before making any changes to your health regimen. For more information visit www.peakformrx.health